Sedative
A sedative is a substance that induces sedation by reducing irritability[1] or excitement.[2]
At higher doses it may result in slurred speech, staggering gait, poor judgment, and slow, uncertain reflexes. Doses of sedatives such as benzodiazepines when used as a hypnotic to induce sleep tend to be higher than those used to relieve anxiety where as only low doses are needed to provide calming sedative effects.[3]
Sedatives can be abused to produce an overly-calming effect (alcohol being the classic and most common sedating drug). At high doses or when they are abused, many of these drugs can cause unconsciousness (see hypnotic) and even death.
Terminology
There is some overlap between the terms "sedative" and hypnotic. Although the effects described by the two terms are different, the medications that cause the effects described by one term often also cause the effects described by the other term.
However, advances in pharmacology have permitted more specific targeting of receptors, and greater selectivity of agents, which necessitates greater precision when describing these agents and their effects:
- Anxiolytic refer specifically to the effect upon anxiety. (However, some benzodiazipines are sedatives, hypnotics, and anxiolytics.)
- Tranquilizer can refer to anxiolytics or antipsychotics.
- Soporific and sleeping pill are near-synonyms for hypnotics.
Types of sedatives
- Herbal sedatives
- ashwagandha
- Duboisia hopwoodii
- Prosanthera striatiflora
- catnip
- kava (Piper methysticum)
- mandrake
- valerian
- Marijuana
- Nonbenzodiazepine "Z-drugs" sedatives
- Other
- Chloral Hydrate
- Alcohol (though not used medically, very popular among the public)
Therapeutic use
Doctors often administer sedatives to patients in order to dull the patient's anxiety related to painful or anxiety-provoking procedures. Although sedatives do not relieve pain in themselves, they can be a useful adjunct to analgesics in preparing patients for surgery, and are commonly given to patients before they are anaesthetized, or before other highly uncomfortable and invasive procedures like cardiac catheterization , colonoscopy or MRI. They increase tractability and compliance of children or troublesome or demanding patients.
Patients in intensive care units are almost always sedated (unless they are unconscious from their condition anyway)
Sedative dependence
All sedatives can cause physiological and psychological dependence when taken regularly over a period of time, even at therapeutic doses.[4][5][6][7] Dependent users may get withdrawal symptoms ranging from restlessness and insomnia to convulsions and death. When users become psychologically dependent, they feel as if they need the drug to function, although physical dependence does not necessarily occur, particularly with a short course of use. In both types of dependences, finding and using the sedative becomes the focus in life. Both physical and psychological dependence can be treated with therapy. (see Sedative Dependence).
Misuse
Main article:
Drug overdose
All sedatives can be misused, but barbiturates and benzodiazepines are responsible for most of the problems with sedative use due to their widespread recreational or non-medical use. People who have difficulty dealing with stress, anxiety or sleeplessness may overuse or become dependent on sedatives. Heroin users take them either to supplement their drug or to substitute for it. Stimulant users frequently take sedatives to calm excessive jitteriness. Others take sedatives recreationally to relax and forget their worries. Barbiturate overdose is a factor in nearly one-third of all reported drug-related deaths. These include suicides and accidental drug poisonings. Accidental deaths sometimes occur when a drowsy, confused user repeats doses, or when sedatives are taken with alcohol. In the U.S., in 1998, a total of 70,982 sedative exposures were reported to U.S. poison control centers, of which 2310 (3.2%) resulted in major toxicity and 89 (0.1%) resulted in death. About half of all the people admitted to emergency rooms in the U.S. as a result of nonmedical use of sedatives have a legitimate prescription for the drug, but have taken an excessive dose or combined it with alcohol or other drugs.[8]
There are also serious paradoxical complications that may occur in conjunction with the use of sedatives that lead to unexpected results in some individuals. Malcolm Lader at the Institute of Psychiatry in London estimates the incidence of these adverse reactions at about 5%, even in short-term use of the drugs. The paradoxical reactions may consist of depression, with or without suicidal tendencies, phobias, aggressiveness, violent behavior and symptoms sometimes misdiagnosed as psychosis.[9]
Dangers of combining sedatives and alcohol
Sedatives and alcohol are sometimes combined recreationally or carelessly. Since alcohol is a strong depressant that slows brain function and depresses respiration, the two substances compound each other's actions and this combination can prove fatal.
Sedatives and amnesia
Sedation can sometimes leave the patient with long-term or short-term amnesia. Lorazepam is one such pharmacological agent that can cause anterograde amnesia. Intensive care unit patients who receive higher doses over longer periods of time, typically via IV drip, are more likely to experience such side effects.
Sedative drugs and crime
Sedatives - most commonly alcohol[10] but also GHB, Flunitrazepam (Rohypnol), and to a lesser extent, temazepam (Restoril), and midazolam (Versed)[11] - are well known for their use as date rape drugs (also called a Mickey) and being administered to unsuspecting patrons in bars or guests at parties to reduce the intended victims' defenses. These drugs are also used for robbing people. Statistical overviews suggest that the use of sedative-spiked drinks for robbing people is actually much more common than their use for rape.[12] Cases of criminals taking rohypnol themselves before they commit crimes have also been reported, as the loss of inhibitions from the drug may increase their confidence to commit the offence, and the amnesia produced by the drug makes it difficult for police to interrogate them if they are caught.
See also
- Benzodiazepine withdrawal syndrome
- Karla Bentham
- antidepressants
- I Wanna Be Sedated
References
- ↑ "Johns Hopkins Colon Cancer Center - Glossary S". http://www.hopkinscoloncancercenter.org/index.cfm?cID=194&CFID=1128737&CFTOKEN=20842936.
- ↑ sedative at Dorland's Medical Dictionary
- ↑ Montenegro M, Veiga H, Deslandes A, et al. (June 2005). "[Neuromodulatory effects of caffeine and bromazepam on visual event-related potential (P300): a comparative study."]. Arq Neuropsiquiatr 63 (2B): 410–5. doi:/S0004-282X2005000300009 (inactive 2010-03-19). PMID 16059590. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2005000300009&lng=en&nrm=iso&tlng=en.
- ↑ Yi PL; Tsai CH, Chen YC, Chang FC (March 2007). "Gamma-aminobutyric acid (GABA) receptor mediates suanzaorentang, a traditional Chinese herb remedy, -induced sleep alteration". J Biomed Sci 14 (2): 285–97. doi:10.1007/s11373-006-9137-z. PMID 17151826.
- ↑ Ebert B; Wafford KA, Deacon S (December 2006). "Treating insomnia: Current and investigational pharmacological approaches". Pharmacol Ther 112 (3): 612–29. doi:10.1016/j.pharmthera.2005.04.014. PMID 16876255.
- ↑ Sarrecchia C; Sordillo P, Conte G, Rocchi G (Oct-December 1998). "[Barbiturate withdrawal syndrome: a case associated with the abuse of a headache medication]". Ann Ital Med Int 13 (4): 237–9. PMID 10349206.
- ↑ Proudfoot H; Teesson M; Australian National Survey of Mental Health and Wellbeing (October 2002). "Who seeks treatment for alcohol dependence? Findings from the Australian National Survey of Mental Health and Wellbeing". Soc Psychiatry Psychiatr Epidemiol 37 (10): 451–6. doi:10.1007/s00127-002-0576-1. PMID 12242622.
- ↑ Professor Jeffrey S Cooper (10 December 2007). "Toxicity, Sedatives". USA: eemedicine. http://emedicine.medscape.com/article/818430-overview. Retrieved 18 December 2008.
- ↑ Benzodiazepines: Paradoxical Reactions & Long-Term Side-Effects
- ↑ Weir E. (July 10, 2001). "Drug-facilitated date rape". Canadian Medical Association Journal (CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.) 165 (1): 80. PMID 11468961. PMC 81265. http://www.cmaj.ca/cgi/content/full/165/1/80.
- ↑ Negrusz A; Gaensslen RE. (August 2003). "Analytical developments in toxicological investigation of drug-facilitated sexual assault". Analytical and bioanalytical chemistry. 376 (8): 1192–7. doi:10.1007/s00216-003-1896-z. PMID 12682705.
- ↑ Thompson, Tony (19 December 2004). "'Rape drug' used to rob thousands". The Observer. http://observer.guardian.co.uk/uk_news/story/0,,1376917,00.html. Retrieved 2008-05-08.
Pharmacology: major drug groups |
|
Gastrointestinal tract/metabolism (A) |
|
|
Blood and blood forming organs (B) |
|
|
Cardiovascular system (C) |
|
|
Skin (D) |
Emollients • Cicatrizants • Antipruritics • Antipsoriatics • Medicated dressings
|
|
Genitourinary system (G) |
Hormonal contraception • Fertility agents • SERMs • Sex hormones
|
|
Endocrine system (H) |
Hypothalamic-pituitary hormones • Corticosteroids ( Glucocorticoids, Mineralocorticoids) • Sex hormones • Thyroid hormones/Antithyroid agents
|
|
Infections and infestations (J, P, QI) |
Antimicrobials: Antibacterials (Antimycobacterials) • Antifungals • Antivirals • Antiparasitics (Antiprotozoals, Anthelmintics, Ectoparasiticides) • IVIG • Vaccines
|
|
Malignant disease (L01-L02) |
Anticancer agents (Antimetabolites, Alkylating, Spindle poisons, Antineoplastic, Topoisomerase inhibitors)
|
|
Immune disease (L03-L04) |
|
|
Muscles, bones, and joints (M) |
|
|
Brain and nervous system (N) |
|
|
Respiratory system (R) |
|
|
Sensory organs (S) |
|
|
Other ATC (V) |
Antidotes • Contrast media • Radiopharmaceuticals • Dressings
|
|
Hypnotics/Sedatives (N05C) |
|
GABAA receptor |
|
Ultrashort-acting
|
|
|
Short/intermediate-
acting
|
Allobarbital • Amobarbital • Butabarbital • Butobarbital • Pentobarbital • Secobarbital • Talbutal
|
|
Long-acting
|
|
|
Ungrouped
|
Cyclobarbital • Ethallobarbital • Heptabarbital • Hexobarbital • Proxibarbal • Reposal • Vinylbital • Vinbarbital
|
|
|
|
Short-acting
|
Brotizolam • Cinolazepam • Doxefazepam • Loprazolam • Midazolam • Triazolam
|
|
Intermediate-acting
|
|
|
Long-acting
|
Flurazepam • Flutoprazepam • Nitrazepam • Quazepam
|
|
|
Dialkylphenols
|
|
|
Nonbenzo-
diazepines
|
CL-218,872 • Eszopiclone • Indiplon • Lirequinil • Necopidem • Pazinaclone • ROD-188 • Saripidem • Suproclone • Suriclone • SX-3228 • U-89843A • U-90042 • Zaleplon • Zolpidem • Zopiclone
|
|
Piperidinediones
|
Glutethimide • Methyprylon • Pyrithyldione • Piperidione
|
|
Quinazolinones
|
Afloqualone • Cloroqualone • Diproqualone • Etaqualone • Mebroqualone • Mecloqualone • Methaqualone • Methylmethaqualone • Nitromethaqualone
|
|
Neuroactive
steroids
|
Acebrochol • Allopregnanolone • Alphadolone • Alphaxolone • Eltanolone • Ganaxolone • Hydroxydione • Minaxolone • Org 20599 • Org 21465 • Tetrahydrodeoxycorticosterone
|
|
|
Alpha-2 adrenergic
receptor |
Alpha-adrenergic agonists
|
4-NEMD • Clonidine • Dexmedetomidine • Lofexidine • Medetomidine • Romifidine • Tizanidine • Xylazine
|
|
|
Melatonin receptor |
|
Agomelatine • Melatonin • Ramelteon • Tasimelteon
|
|
|
Histamine receptor &
Acetylcholine receptor |
|
|
5-HT2A &
α1-adrenergic |
Selective 5-HT2A & α1-adrenergic antagonists
|
Etoperidone • Nefazodone • Niaprazine • Trazodone
|
|
|
GABAB receptor /
GHB receptor |
|
|
Orexin receptors |
Orexin antagonists
|
Almorexant • SB-334,867 • SB-408,124 • SB-649,868 • TCS-OX2-29
|
|
|
Other receptors/
ungrouped |
|
Acetylglycinamide chloral hydrate • Chloral hydrate • Chloralodol • Dichloralphenazone • Paraldehyde • Petrichloral
|
|
|
Centalun • Ethchlorvynol • Ethinamate • Hexapropymate • Methylpentynol
|
|
Carbamates
|
Meprobamate • Carisoprodol • Tybamate • Methocarbamol • Procymate
|
|
Other
|
2-Methyl-2-butanol • Acecarbromal • Acetophenone • Apronal • Bromides • Bromisoval • Carbromal • Chloralose • Clomethiazole • Embutramide • Etomidate • Evoxine • Fenadiazole • Gaboxadol • Loreclezole • Mephenoxalone • Sulfonmethane • Trichloroethanol • Triclofos • Valerian • Valnoctamide
|
|
#WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III
|
|
dsrd (o, p, m, p, a, d, s), sysi/, spvo
|
|
|
|
|
|